GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

Clinical trial NCT04864054 · RECRUITING

Trial details

NCT number: NCT04864054
Sponsor: Eureka Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Liver Cancer, Adult Liver Neoplasm Metastatic Liver Cancer

Start date: 2022-03-11
Primary completion: 2027-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.